Context Therapeutics Inc (CNTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Operating Expenses | 3,443 | 3,092 | 1,568 | 5,026 | 840 |
| Operating Income | -3,443 | -3,092 | -1,568 | -5,026 | -840 |
| Interest Expense | 0 | 126 | 1 | 0 | -63 |
| Other Income | 5 | 18 | 127 | -4 | -7 |
| Pre-tax Income | -3,438 | -3,199 | -1,443 | -5,030 | -785 |
| Net Income Continuous | -3,438 | -3,199 | -1,443 | -5,030 | -785 |
| Net Income | $-3,438 | $-3,199 | $-1,443 | $-5,030 | $-785 |
| EPS Basic Total Ops | -0.22 | 17.04 | -4.00 | -14.18 | -2.55 |
| EPS Basic Continuous Ops | -0.22 | 16.72 | -4.00 | -14.17 | -2.25 |
| EPS Diluted Total Ops | -0.22 | 17.04 | -4.00 | -14.18 | -2.55 |
| EPS Diluted Continuous Ops | -0.22 | 16.72 | -4.00 | -14.17 | -2.25 |
| EBITDA(a) | $-3,443 | $-3,092 | $-1,568 | $-5,026 | $-840 |